When the headlines are wrong...

The oldest way to make money in this business is to find a situation where the headline says one thing and the facts say another.

In January the FDA rejected a drug and the stock lost half its value in 3 weeks.

There were no safety deficiencies, efficacy deficiencies, or manufacturing deficiencies. The problem was a foil pouch that took too long to open and a film that some patients placed wrong. Science was never in question.

The market cannot tell the difference between a drug that failed and a package that failed. And THAT gap is where money gets made.

My friend Sam Kovacs did the work nobody else bothered to do:

There is no published approval rate for rejections like this one, so he built the dataset himself by hand.

This is what REAL research looks like. Not a narrative or stupid hot take.

Sam has been publishing this quality of work for free for two months. And on Saturday he finally launches his premium publication.

I highly suggest you check out his work: